4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-25-018887
President and CEO gave up 12,547 shares (to pay taxes)
- President and CEO acquired 31,249 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-11 | Exercise or conversion : show line 1 in the form | +31,249 | 226,091 | D | ||
| 2025-02-11 | Shares withheld for taxes : show line 2 in the form | −12,547 | $0.65 | $8,156 | 213,544 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-11 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −31,249 | 31,250 | D |
Loading xslF345X05/ownership.xml…